Literature DB >> 30950170

Helicobacter pylori infection and nonalcoholic fatty liver disease: Time for large clinical trials evaluating eradication therapy.

Stergios A Polyzos1, Jannis Kountouras2.   

Abstract

Entities:  

Keywords:  zzm321990Helicobacter pylorizzm321990; homeostasis model assessment; insulin resistance; metabolic syndrome; nonalcoholic fatty liver disease; nonalcoholic steatohepatitis

Mesh：

Substances：

Year:  2019        PMID： 30950170     DOI： 10.1111/hel.12588

Source DB:  PubMed          Journal:  Helicobacter        ISSN： 1083-4389            Impact factor:   5.753


× No keyword cloud information.
  4 in total

1.  Association Between Helicobacter Pylori Infection and Non-alcoholic Fatty Liver Disease, Hepatic Adipose Deposition and Stiffness in Southwest China.

Authors:  Ying Liu; Dongyu Li; Yuping Liu; Ping Shuai
Journal:  Front Med (Lausanne)       Date:  2021-12-24

2.  Oxidative stress and cardiometabolic biomarkers in patients with non-alcoholic fatty liver disease.

Authors:  Aleksandra Klisic; Nebojsa Kavaric; Ana Ninic; Jelena Kotur-Stevuljevic
Journal:  Sci Rep       Date:  2021-09-16       Impact factor: 4.379

3.  Is the Occurrence or Reversal of Nonalcoholic Fatty Liver Disease Associated with Long-Term Helicobacter pylori Infection among Chinese Adults? A Cohort Study.

Authors:  Xia-Xia Zhao; Rui-Ling Wang; Ming-Hao Liu; Xiao-Jun Huang
Journal:  Gastroenterol Res Pract       Date:  2021-11-24       Impact factor: 2.260

4.  Active Helicobacter pylori Infection is Independently Associated with Nonalcoholic Steatohepatitis in Morbidly Obese Patients.

Authors:  Michael Doulberis; Simone Srivastava; Stergios A Polyzos; Jannis Kountouras; Apostolis Papaefthymiou; Jolanta Klukowska-Rötzler; Annika Blank; Aristomenis K Exadaktylos; David S Srivastava
Journal:  J Clin Med       Date:  2020-03-30       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.